SPC
SNDX icon

Sigma Planning Corp’s Syndax Pharmaceuticals SNDX Stock Holding History

Sigma Planning Corp’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-16,985
Closed -$209K – 1332
2025
Q1 		$209K Sell
16,985
-800
-4% -$11.3K 0.01% 1114
2024
Q4 		$235K Sell
17,785
-950
-5% -$16.3K 0.01% 1024
2024
Q3 		$361K Sell
18,735
-200
-1% -$4.13K 0.01% 880
2024
Q2 		$389K Sell
18,935
-900
-5% -$18.8K 0.01% 824
2024
Q1 		$472K Buy
+19,835
New +$442K 0.01% 788
2023
Q4 		– Sell
-20,750
Closed -$301K – 1129
2023
Q3 		$301K Sell
20,750
-10
-0% -$189 0.01% 920
2023
Q2 		$435K Sell
20,760
-2,490
-11% -$51.8K 0.02% 788
2023
Q1 		$491K Sell
23,250
-2,690
-10% -$66.9K 0.02% 798
2022
Q4 		$660K Buy
25,940
+300
+1% +$7K 0.02% 652
2022
Q3 		$616K Buy
25,640
+1,800
+8% +$40.4K 0.02% 649
2022
Q2 		$459K Sell
23,840
-750
-3% -$12.5K 0.02% 792
2022
Q1 		$427K Hold
24,590
– – 0.01% 904
2021
Q4 		$538K Sell
24,590
-200
-0.8% -$3.69K 0.02% 821
2021
Q3 		$474K Sell
24,790
-450
-2% -$7.5K 0.01% 848
2021
Q2 		$433K Sell
25,240
-200
-0.8% -$3.66K 0.01% 895
2021
Q1 		$569K Sell
25,440
-85
-0.3% -$1.92K 0.02% 717
2020
Q4 		$568K Sell
25,525
-600
-2% -$12.4K 0.02% 648
2020
Q3 		$386K Buy
26,125
+100
+0.4% +$1.52K 0.02% 699
2020
Q2 		$386K Buy
+26,025
New +$396K 0.02% 689
2019
Q3 		– Sell
-12,280
Closed -$114K – 1058
2019
Q2 		$114K Buy
+12,280
New +$89.5K 0.01% 949

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Sigma Planning Corp's SNDX Position: Q2 2025 in Review

Sigma Planning Corp sold out of Syndax Pharmaceuticals (SNDX) in Q2 2025, closing a stake of 16,985 shares — an estimated $209K sold.

Sigma Planning Corp first reported a position in SNDX in Q2 2019 and held it in 20 quarters. The position peaked at $660K in Q4 2022. 216 funds tracked by Wall St. Rank hold SNDX as of Q2 2025.

  • Sigma Planning Corp reported no remaining Syndax Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Sigma Planning Corp sold 16,985 Syndax Pharmaceuticals shares in Q2 2025, an estimated $209K.
  • Sigma Planning Corp first reported a position in Syndax Pharmaceuticals in Q2 2019 and held it in 20 quarters.
  • Sigma Planning Corp's Syndax Pharmaceuticals position peaked at $660K in Q4 2022.
  • 216 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2025.

Based on Sigma Planning Corp's 13F filing for Q2 2025, filed 5 Aug 2025.